日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial

在 ASC4FIRST 试验中,Asciminib 在新诊断的慢性粒细胞白血病患者中展现出优异的疗效和安全性。

Cortes, Jorge E; Hughes, Timothy P; Wang, Jianxiang; Kim, Dong-Wook; Kim, Dennis Dong Hwan; Mayer, Jiri; Goh, Yeow-Tee; le Coutre, Philipp; Etienne, Gabriel; Kim, Inho; Andorsky, David J; Bombaci, Felice; Issa, Ghayas C; Takahashi, Naoto; Kapoor, Shruti; Jinwal, Rajendra; Malek, Kamel; McCulloch, Tracey; Yau, Lillian; Larson, Richard A; Hochhaus, Andreas

Imatinib outcomes in chronic myeloid leukemia across diverse health care settings: a systematic review and meta-analysis

伊马替尼治疗慢性粒细胞白血病在不同医疗机构中的疗效:系统评价和荟萃分析

Miranda-Galvis, Marisol; Wilson, Joshua; Reategui-Almonacid, Yazmin; Johnston, Lily; Taylor, Allison O; Sadek, Ramses; Tjioe, Kellen; Cortes, Jorge E

BCR-ABL1 Drives Transcriptional Reprogramming of Chronic Myeloid Leukemia Cells for Immune Evasion Through C/EBPβ

BCR-ABL1通过C/EBPβ驱动慢性粒细胞白血病细胞的转录重编程以实现免疫逃逸

Lu, Xiaocui; Fang, Hui; Liu, Yuan; Liu, Chang; Fang, Xuexiu; Matsunaga, Atsuko; Mori, Stephanie F; Zhang, Ting; Wang, Gavin; Zhou, George I; Yu, Miao; Ding, Haocheng; Cortes, Jorge; Cheng, Bo; Hu, Tianxiang

Geographic, Racial, and Sex Disparities in Time to Treatment for Early-Onset Colorectal Cancer

早期结直肠癌治疗时间方面的地域、种族和性别差异

Tsai, Meng-Han; Coughlin, Steven S; Cortes, Jorge; Vega, Kenneth J

Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey

改善慢性粒细胞白血病管理和生活质量:来自 CML SUN 调查的患者和医生未满足需求调查

Lang, Fabian; Pemberton-Whiteley, Zack; Clements, Joannie; Ruiz, Cristina; Rea, Delphine; Machado, Lisa; Takahashi, Naoto; Moon, Sung-Ho; Grigg, Andrew; Borowczak, Cornelia; Schuld, Peter; Frank, Pauline; Constantinescu, Cristina; Boquimpani, Carla; Cortes, Jorge E

Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial"

更正:“在QuANTUM-First试验中,造血细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响”

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P

FLT3-ITD measurable residual disease from the QuANTUM-First trial

Quantum-First试验中FLT3-ITD可测量残留病灶

Levis, Mark J; Erba, Harry P; Montesinos, Pau; Kim, Hee-Je; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Connolly Rohrbach, Jaime E; Chang, Ken C N; Liu, Li; Mostafa Kamel, Yasser; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Schlenk, Richard F; Perl, Alexander E

Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia

异柠檬酸脱氢酶 1 突变复发/难治性急性髓系白血病中 Olutasidenib 和 Ivosidenib 的匹配调整间接比较

Watts, Justin M; Wang, Eunice S; Jonas, Brian A; Wilson, Florence R; Park, Julie E; Cope, Shannon; Sheppard, Aaron; Thomassen, Amber; de Botton, Stéphane; Cortes, Jorge E

Treatment Delays and Survival Divides: Race, Sex, and Early-Onset Colorectal Cancer Disparities

治疗延误与生存差异:种族、性别与早发性结直肠癌的差异

Tsai, Meng-Han; Cortes, Jorge E; Lee, Minjee; Sifuentes, Humberto; Bae, Sejong

Geographic and Demographic Disparities in Receipt of Treatment for Early-Onset Colorectal Cancer

早期结直肠癌治疗接受率的地域和人口统计学差异

Tsai, Meng-Han; Coughlin, Steven S; Cortes, Jorge